33,790 Shares in Molina Healthcare, Inc $MOH Purchased by Castleark Management LLC

Castleark Management LLC purchased a new stake in Molina Healthcare, Inc (NYSE:MOH) during the second quarter, HoldingsChannel.com reports. The firm purchased 33,790 shares of the company’s stock, valued at approximately $7,728,000.

Several other large investors have also recently bought and sold shares of the stock. Elevation Wealth Partners LLC increased its stake in shares of Molina Healthcare by 118.2% during the second quarter. Elevation Wealth Partners LLC now owns 144 shares of the company’s stock worth $33,000 after purchasing an additional 78 shares during the period. Torren Management LLC bought a new stake in Molina Healthcare in the 4th quarter valued at $26,000. MUFG Securities EMEA plc bought a new stake in Molina Healthcare in the 2nd quarter valued at $48,000. Global Retirement Partners LLC acquired a new position in Molina Healthcare in the 2nd quarter valued at $39,000. Finally, Quarry LP acquired a new position in Molina Healthcare in the 4th quarter valued at $32,000. 98.50% of the stock is owned by institutional investors.

Molina Healthcare Stock Performance

MOH opened at $199.79 on Wednesday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.68 and a current ratio of 1.68. Molina Healthcare, Inc has a 52-week low of $121.06 and a 52-week high of $244.89. The firm has a market cap of $10.43 billion, a P/E ratio of -1,109.88, a price-to-earnings-growth ratio of 28.44 and a beta of 0.75. The business’s fifty day moving average is $211.20 and its 200-day moving average is $178.83.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Wednesday, July 22nd. The company reported $1.51 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.12. Molina Healthcare had a positive return on equity of 3.73% and a negative net margin of 0.02%.The business had revenue of $10.87 billion during the quarter, compared to the consensus estimate of $10.83 billion. During the same quarter in the previous year, the firm earned $5.48 earnings per share. Molina Healthcare’s revenue for the quarter was down 4.8% compared to the same quarter last year. Sell-side analysts expect that Molina Healthcare, Inc will post 5.29 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Robert W. Baird lifted their target price on Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a report on Monday, May 11th. TD Cowen upped their price target on shares of Molina Healthcare from $163.00 to $230.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Truist Financial lowered their price target on shares of Molina Healthcare from $250.00 to $225.00 and set a “hold” rating on the stock in a research report on Friday, July 24th. Cantor Fitzgerald reissued a “neutral” rating on shares of Molina Healthcare in a report on Friday, July 24th. Finally, Jefferies Financial Group set a $230.00 target price on shares of Molina Healthcare in a report on Tuesday, July 14th. Three research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Molina Healthcare has a consensus rating of “Hold” and a consensus price target of $202.44.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.